Institutional Ownership Crinetics Pharmaceuticals, Inc. (CRNX)
This table provides information about the institutional ownership of Crinetics Pharmaceuticals, Inc. (CRNX). We have compiled data on the 235 institutions that hold shares in the stock, with a total of 87 Million shares, which have been reported (via 13F filing form) to have a value of $2.72 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Abrdn PLC
|
May 13, 2025 Q1 2025 |
208,059
shares
|
$6.5 Million
0.01% of portfolio
|
Q1 2025
Added 379.52%
|
|
|
Ameriprise Financial Inc
Minneapolis, MN |
May 14, 2025 Q1 2025 |
205,054
shares
|
$6.41 Million
0.0% of portfolio
|
Q1 2025
Reduced 42.27%
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
May 09, 2025 Q1 2025 |
204,122
shares
|
$6.38 Million
0.0% of portfolio
|
Q1 2025
Reduced 3.4%
|
|
|
Decheng Capital LLC
Menlo Park, CA |
May 07, 2025 Q1 2025 |
177,958
shares
|
$5.56 Million
1.67% of portfolio
|
Q1 2025
Added 5.95%
|
|
|
Td Asset Management Inc
|
May 07, 2025 Q1 2025 |
174,694
shares
|
$5.46 Million
0.01% of portfolio
|
Q1 2025
Reduced 23.72%
|
|
|
Russell Investments Group, Ltd.
|
May 13, 2025 Q1 2025 |
166,338
shares
|
$5.2 Million
0.01% of portfolio
|
Q1 2025
Added 386.37%
|
|
|
Barclays PLC
London, X0 |
May 15, 2025 Q1 2025 |
165,911
shares
|
$5.18 Million
0.0% of portfolio
|
Q1 2025
Reduced 8.81%
|
|
|
Swiss National Bank
Zurich, V8 |
May 12, 2025 Q1 2025 |
161,800
shares
|
$5.05 Million
0.0% of portfolio
|
Q1 2025
Added 1.51%
|
|
|
Affinity Asset Advisors, LLC
New York, NY |
May 14, 2025 Q1 2025 |
152,252
shares
|
$4.76 Million
0.57% of portfolio
|
Q1 2025
Reduced 66.9%
|
|
|
Citigroup Inc
|
May 12, 2025 Q1 2025 |
150,050
shares
|
$4.69 Million
0.0% of portfolio
|
Q1 2025
Added 24.26%
|
|
|
Ghost Tree Capital, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
150,000
shares
|
$4.69 Million
2.87% of portfolio
|
Q3 2024
Reduced 37.5%
|
|
|
Segall Bryant & Hamill, LLC
Chicago, IL |
May 02, 2025 Q1 2025 |
146,274
shares
|
$4.57 Million
0.08% of portfolio
|
Q1 2025
Reduced 2.74%
|
|
|
New Leaf Venture Partners, L.L.C.
New York, NY |
May 13, 2025 Q1 2025 |
141,000
shares
|
$4.4 Million
10.63% of portfolio
|
Q3 2019
Reduced 15.92%
|
|
|
Boothbay Fund Management, LLC
New York, NY |
May 15, 2025 Q1 2025 |
139,973
shares
|
$4.37 Million
0.14% of portfolio
|
Q1 2025
Added 1.61%
|
|
|
Moody Aldrich Partners LLC
|
Apr 28, 2025 Q1 2025 |
139,905
shares
|
$4.37 Million
1.1% of portfolio
|
Q1 2025
Reduced 3.09%
|
|
|
Squarepoint Ops LLC
New York, NY |
May 15, 2025 Q1 2025 |
139,492
shares
|
$4.36 Million
0.01% of portfolio
|
Q1 2025
New holding
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
May 14, 2025 Q1 2025 |
138,035
shares
|
$4.31 Million
0.0% of portfolio
|
Q1 2025
Added 174.69%
|
|
|
New York State Common Retirement Fund
|
May 01, 2025 Q1 2025 |
137,918
shares
|
$4.31 Million
0.01% of portfolio
|
Q1 2025
Reduced 11.26%
|
|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
May 15, 2025 Q1 2025 |
134,793
shares
|
$4.21 Million
0.0% of portfolio
|
Q1 2025
Reduced 9.51%
|
|
|
Rhumbline Advisers
Boston, MA |
Apr 08, 2025 Q1 2025 |
131,950
shares
|
$4.12 Million
0.0% of portfolio
|
Q1 2025
Added 6.34%
|
|
|
Monarch Partners Asset Management LLC
|
Feb 02, 2023 Q4 2022 |
128,974
shares
|
$4.03 Million
0.72% of portfolio
|
Q4 2022
Reduced 1.44%
|
|
|
Integral Health Asset Management, LLC
|
May 15, 2025 Q1 2025 |
125,000
shares
|
$3.91 Million
0.49% of portfolio
|
Q1 2025
Reduced 58.33%
|
|
|
Walleye Capital LLC
Plymouth, MN |
May 14, 2025 Q1 2025 |
123,982
shares
|
$3.87 Million
0.02% of portfolio
|
Q1 2025
Reduced 12.59%
|
|
|
Pier Capital, LLC
Stamford, CT |
May 13, 2025 Q1 2025 |
113,412
shares
|
$3.54 Million
0.67% of portfolio
|
Q1 2025
Added 1.26%
|
|
|
Alliancebernstein L.P.
New York, NY |
May 15, 2025 Q1 2025 |
110,674
shares
|
$3.46 Million
0.0% of portfolio
|
Q1 2025
Added 8.8%
|